Corporate report

Psychoactive Substances Bill: evaluation review

An evaluation review of the Psychoactive Substances Bill by the Advisory Council on the Misuse of Drugs (ACMD).


ACMD comments on the draft review framework document for the Psychoactive Substances Bill

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This ACMD report provides further advice and recommendations about the Psychoactive Substances Bill.

Published 14 July 2017